, Question 1
A patient with severe hypoalbuminemia (serum albumin 1.8 g/dL) is receiving
a highly protein-bound beta-lactam (95% bound). Which pharmacokinetic
consequence is most likely, and how should dosing be interpreted?
A. Total drug concentration falls, free fraction rises, and pharmacologic
effect may increase despite normal total levels.
B. Total drug concentration rises, free fraction falls, and toxicity risk
decreases.
C. Both free and total drug concentrations remain unchanged because
protein binding is saturated.
D. Volume of distribution decreases and half-life prolongs due to reduced
binding sites.
Correct Answer: A - Total drug concentration falls, free fraction
rises, and pharmacologic effect may increase despite normal total
levels.
RATIONALE
In hypoalbuminemia, fewer binding sites reduce the bound fraction,
lowering total drug concentration while increasing the free (active)
fraction. Because only free drug is pharmacologically active, effect
can be enhanced and toxicity risk may rise even when total levels
appear normal. The other options incorrectly describe binding or
distribution changes.
Question 2
Which pharmacodynamic property best explains why beta-lactam antibiotics
require frequent or prolonged infusion dosing rather than large intermittent
boluses?
A. Concentration-dependent killing with a long post-antibiotic effect
B. Time-dependent killing with minimal post-antibiotic effect
C. Concentration-dependent killing with a short post-antibiotic effect
Page 2
, D. Time-dependent killing with a long post-antibiotic effect
Correct Answer: B - Time-dependent killing with minimal
post-antibiotic effect
RATIONALE
Beta-lactams exhibit time-dependent killing, where efficacy correlates
with the duration that free drug concentration exceeds the MIC
(T>MIC). They have minimal to no post-antibiotic effect against most
gram-negative organisms, so maintaining levels above MIC for a large
portion of the dosing interval is critical. Concentration-dependent
killing and long PAE are characteristic of aminoglycosides, not
beta-lactams.
Question 3
A patient is prescribed IV vancomycin for MRSA bacteremia. The AUC/MIC
ratio is the target pharmacodynamic index. Which monitoring strategy best
reflects current consensus guidelines to ensure efficacy and minimize
nephrotoxicity?
A. Peak serum concentration 1 hour after infusion, targeting 30-40
mcg/mL
B. Trough serum concentration targeting 5-10 mcg/mL
C. AUC24/MIC ratio of 400-600 using Bayesian software or two serum
levels
D. Random serum level at any time, targeting 15-20 mcg/mL
Correct Answer: C - AUC24/MIC ratio of 400-600 using Bayesian
software or two serum levels
Page 3
, RATIONALE
Current vancomycin guidelines recommend AUC24/MIC-guided
dosing (target 400-600) for serious MRSA infections to maximize
efficacy while reducing nephrotoxicity compared with high
trough-only monitoring. Trough-only targets (15-20 mcg/mL) are
associated with increased AKI and are no longer preferred when AUC
monitoring is available. Peak levels and random levels are not
validated for vancomycin efficacy.
Question 4
A patient with a beta-lactam allergy history is to receive aztreonam. Which
statement about cross-reactivity is most accurate?
A. Aztreonam cross-reacts significantly with penicillins due to shared
beta-lactam ring.
B. Aztreonam has minimal cross-reactivity with penicillins but may
cross-react with ceftazidime.
C. Aztreonam cross-reacts with all cephalosporins because of identical
side chains.
D. Aztreonam is contraindicated in any patient with a cephalosporin
allergy.
Correct Answer: B - Aztreonam has minimal cross-reactivity with
penicillins but may cross-react with ceftazidime.
RATIONALE
Aztreonam is a monobactam with a unique side chain that rarely
cross-reacts with penicillins or most cephalosporins, except
ceftazidime, which shares an identical R1 side chain. Therefore, it can
often be used safely in patients with penicillin allergy, but caution is
needed if ceftazidime allergy exists. The other options overstate
cross-reactivity.
Page 4
A patient with severe hypoalbuminemia (serum albumin 1.8 g/dL) is receiving
a highly protein-bound beta-lactam (95% bound). Which pharmacokinetic
consequence is most likely, and how should dosing be interpreted?
A. Total drug concentration falls, free fraction rises, and pharmacologic
effect may increase despite normal total levels.
B. Total drug concentration rises, free fraction falls, and toxicity risk
decreases.
C. Both free and total drug concentrations remain unchanged because
protein binding is saturated.
D. Volume of distribution decreases and half-life prolongs due to reduced
binding sites.
Correct Answer: A - Total drug concentration falls, free fraction
rises, and pharmacologic effect may increase despite normal total
levels.
RATIONALE
In hypoalbuminemia, fewer binding sites reduce the bound fraction,
lowering total drug concentration while increasing the free (active)
fraction. Because only free drug is pharmacologically active, effect
can be enhanced and toxicity risk may rise even when total levels
appear normal. The other options incorrectly describe binding or
distribution changes.
Question 2
Which pharmacodynamic property best explains why beta-lactam antibiotics
require frequent or prolonged infusion dosing rather than large intermittent
boluses?
A. Concentration-dependent killing with a long post-antibiotic effect
B. Time-dependent killing with minimal post-antibiotic effect
C. Concentration-dependent killing with a short post-antibiotic effect
Page 2
, D. Time-dependent killing with a long post-antibiotic effect
Correct Answer: B - Time-dependent killing with minimal
post-antibiotic effect
RATIONALE
Beta-lactams exhibit time-dependent killing, where efficacy correlates
with the duration that free drug concentration exceeds the MIC
(T>MIC). They have minimal to no post-antibiotic effect against most
gram-negative organisms, so maintaining levels above MIC for a large
portion of the dosing interval is critical. Concentration-dependent
killing and long PAE are characteristic of aminoglycosides, not
beta-lactams.
Question 3
A patient is prescribed IV vancomycin for MRSA bacteremia. The AUC/MIC
ratio is the target pharmacodynamic index. Which monitoring strategy best
reflects current consensus guidelines to ensure efficacy and minimize
nephrotoxicity?
A. Peak serum concentration 1 hour after infusion, targeting 30-40
mcg/mL
B. Trough serum concentration targeting 5-10 mcg/mL
C. AUC24/MIC ratio of 400-600 using Bayesian software or two serum
levels
D. Random serum level at any time, targeting 15-20 mcg/mL
Correct Answer: C - AUC24/MIC ratio of 400-600 using Bayesian
software or two serum levels
Page 3
, RATIONALE
Current vancomycin guidelines recommend AUC24/MIC-guided
dosing (target 400-600) for serious MRSA infections to maximize
efficacy while reducing nephrotoxicity compared with high
trough-only monitoring. Trough-only targets (15-20 mcg/mL) are
associated with increased AKI and are no longer preferred when AUC
monitoring is available. Peak levels and random levels are not
validated for vancomycin efficacy.
Question 4
A patient with a beta-lactam allergy history is to receive aztreonam. Which
statement about cross-reactivity is most accurate?
A. Aztreonam cross-reacts significantly with penicillins due to shared
beta-lactam ring.
B. Aztreonam has minimal cross-reactivity with penicillins but may
cross-react with ceftazidime.
C. Aztreonam cross-reacts with all cephalosporins because of identical
side chains.
D. Aztreonam is contraindicated in any patient with a cephalosporin
allergy.
Correct Answer: B - Aztreonam has minimal cross-reactivity with
penicillins but may cross-react with ceftazidime.
RATIONALE
Aztreonam is a monobactam with a unique side chain that rarely
cross-reacts with penicillins or most cephalosporins, except
ceftazidime, which shares an identical R1 side chain. Therefore, it can
often be used safely in patients with penicillin allergy, but caution is
needed if ceftazidime allergy exists. The other options overstate
cross-reactivity.
Page 4
